Erythromycin and Scab - a phase IV clinical study of FDA data

Summary:

Scab is reported as a side effect among people who take Erythromycin (erythromycin), especially for people who are female, 2-9 old, have been taking the drug for < 1 month also take Accutane, and have Headache.

The phase IV clinical study analyzes which people have Scab when taking Erythromycin. It is created by eHealthMe based on reports of 12,069 people who have side effects when taking Erythromycin from the FDA, and is updated regularly.

What is Erythromycin?

Erythromycin has active ingredients of erythromycin. It is often used in acne. eHealthMe is studying from 12,563 Erythromycin users. Check the latest studies of Erythromycin.

What is Scab?

Scab (a hard coating on the skin formed during the wound healing) is found to be associated with 858 drugs and 1,081 conditions by eHealthMe. Check the latest studies of Scab.

On Jul, 14, 2026

12,069 people reported to have side effects when taking Erythromycin.
Among them, 14 people (0.12%) have Scab.

Among these 14 people:

How long have people been on Erythromycin when they have Scab? *

What is the gender of people who have Scab when taking Erythromycin? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Scab when taking Erythromycin? *

What are other drugs people take besides Erythromycin? *

What are other side effects people have besides Scab? *

Fatigue (feeling of tiredness): 6 people, 42.86%
Rashes (redness): 6 people, 42.86%
Stress And Anxiety: 5 people, 35.71%
Weakness: 4 people, 28.57%
Diarrhea: 4 people, 28.57%
Anaemia (lack of blood): 4 people, 28.57%
Tumor: 3 people, 21.43%
Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 21.43%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 3 people, 21.43%
Erythema Multiforme (a type of hypersensitivity reaction): 3 people, 21.43%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 2 people, 14.29%
Parapsoriasis (chronic dermatosis of unknown origin, with erythematous , papular, and scaling lesions appearing in): 2 people, 14.29%
Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 2 people, 14.29%
Ill-Defined Disorder: 2 people, 14.29%
Headache (pain in head): 2 people, 14.29%
Seborrheic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 1 person, 7.14%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 7.14%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.14%
Gastric Ulcer (stomach ulcer): 1 person, 7.14%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Erythromycin and have Scab?

- Check whether Scab is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Erythromycin:

Erythromycin (12,563 reports)

Scab treatments and more:

Scab (12,679 reports)

Browse all side effects of Erythromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Scab:

Scab (858 drugs)

Browse all the conditions that are associated with Scab:

Scab (1,081 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on erythromycin (the active ingredients of Erythromycin) and Erythromycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.